Indomethacin
Indomethacin is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Indomethacin; Generic name: INDOMETHACIN; Drug class: Nonsteroidal Anti-inflammatory Drug [EPC].
| Brand name | Indomethacin |
|---|---|
| Generic name | INDOMETHACIN |
| Drug class | Nonsteroidal Anti-inflammatory Drug [EPC] |
| Manufacturer | Sportpharm LLC |
| Used for | 1 INDICATIONS AND USAGE Indomethacin extended-release capsules are indicated for: • Moderate to severe rheumatoid arthritis including acute flares of chronic disease • Moderate to severe ankylosing spondylitis • Moderate to severe osteoarthritis • Acute painful shoulder (bursitis and/or tendinitis) Indomethacin extended-release capsules are a nonsteroidal anti-inflammatory drug indicated for: • Moderate to severe rheumatoid arthritis including acute flares of chronic disease • Moderate to severe ankylosing spondylitis • Moderate to severe osteoarthritis • Acute painful shoulder (bursitis and/or tendinitis) ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION • Use the lowest effective dosage for shortest duration consistent with individual patient treatment goals ( 2.1 ) • The dosage for moderate to severe rheumatoid arthritis including acute flares of chronic disease; moderate to severe ankylosing spondylitis; and moderate to severe osteoarthritis is one indomethacin extended-release 75 mg capsule daily ( 2.2 ) • The dosage for acute painful shoulder (bursitis and/or tendinitis) is one indomethacin extended-release 75 mg |
| Warnings | WARNING: RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS Cardiovascular Thrombotic Events • Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use [see Warnings and Precautions (5.1) ]. • Indomethacin extended-release capsules are contraindicated in the setting of coronary artery bypass |
| Active ingredient(s) | INDOMETHACIN |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=12821a3a-b5f2-4415-84c9-0a30a4725f1e |